 Eiger BioPharmaceuticals, Inc. NASDAQ:EIGR Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory - President CEO Ingrid Choong - SVP-Clinical Development Eldon Mayer - Chief Commercial Officer Sriram Ryali - CFO Colleen Craig - VP-Metabolic Diseases Conference Call Participants Maurice Raycroft - Jefferies Robert Hazlett - BTIG Michael Higgins - Ladenburg Thalmann Operator Starts Abruptly and business update conference call. At this times, all participants are in a listen-only mode. 